Bcl-XL is functionally non-equivalent for the regulation of growth and survival in human ovarian cancer cells

This publication has 19 references indexed in Scilit:

• Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease
  Gynecologic Oncology, 2005
• Apoptosis: A Link between Cancer Genetics and Chemotherapy
  Published by Elsevier ,2002
• Molecular mechanisms of “detachment-induced apoptosis—Anoikis”
  Apoptosis, 2002
• Acquired alkylating drug resistance of a human ovarian carcinoma cell line is unaffected by altered levels of pro- and anti-apoptotic proteins
  Oncogene, 2000
• Epithelial ovarian cancer: prevention, diagnosis, and treatment
  CA: A Cancer Journal for Clinicians, 1999
• BCL-2 family members and the mitochondria in apoptosis
  Genes & Development, 1999
• Bcl-xLIs Expressed in Ovarian Carcinoma and Modulates Chemotherapy-Induced Apoptosis
  Gynecologic Oncology, 1998
• The Bcl-2 Protein Family: Arbiters of Cell Survival
  Science, 1998
• Bcl-2 and Bcl-XL Can Differentially Block Chemotherapy-Induced Cell Death
  Blood, 1997
• Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2.
  Proceedings of the National Academy of Sciences, 1994